MedTrace Logo

Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients

NCT00466804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 263

Last updated 2016-01-01

No results posted yet for this study

Summary

Injury of transplant tissue by a transplant recipient's immune system continues to be the leading cause of graft rejection and recipient death. The purpose of this study is to identify a single test or a combination of noninvasive tests currently used for heart transplant monitoring that correlate to long-term graft survival.

Conditions

  • Heart Transplant

Interventions

PROCEDURE

Heart transplant

People in this study will have a heart transplant and be monitored for signs of rejection

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Clinical Trials in Organ Transplantation

    collaborator NETWORK

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Peter S. Heeger, MD · Icahn School of Medicine at Mount Sinai

  • Mohamed H. Sayegh, MD · Brigham and Women's Hospital

  • Randall Starling, MD · The Cleveland Clinic

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00466804 on ClinicalTrials.gov